patients undergo cVATS segmentectomy
FAH-GZU-001
Phase 3 other active
Quick answer
patients undergo cVATS segmentectomy for Non-small Cell Lung Cancer Stage I is a Phase 3 program (other) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Non-small Cell Lung Cancer Stage I
- Phase
- Phase 3
- Modality
- other
- Status
- active